Hamel Associates’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.82M | Sell |
|
|||||
|
2025
Q1 | $4.34M | Buy |
|
|||||
|
2024
Q4 | $3.65M | Hold |
|
|||||
|
2024
Q3 | $4.06M | Hold |
|
|||||
|
2024
Q2 | $3.53M | Sell |
|
|||||
|
2024
Q1 | $4.41M | Sell |
|
|||||
|
2023
Q4 | $4.21M | Sell |
|
|||||
|
2023
Q3 | $4.09M | Hold |
|
|||||
|
2023
Q2 | $3.69M | Sell |
|
|||||
|
2023
Q1 | $4.41M | Sell |
|
|||||
|
2022
Q4 | $4.48M | Sell |
|
|||||
|
2022
Q3 | $3.75M | Sell |
|
|||||
|
2022
Q2 | $4.33M | Sell |
|
|||||
|
2022
Q1 | $4.62M | Sell |
|
|||||
|
2021
Q4 | $3.86M | Buy |
|
|||||
|
2021
Q3 | $3.07M | Buy |
|
|||||
|
2021
Q2 | $3.06M | Buy |
|
|||||
|
2021
Q1 | $1.5M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $208K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $631K | Sell |
|
|||||
|
2016
Q3 | $728K | Sell |
|
|||||
|
2016
Q2 | $1.33M | Sell |
|
|||||
|
2016
Q1 | $1.3M | Sell |
|
|||||
|
2015
Q4 | $1.36M | Sell |
|
|||||
|
2015
Q3 | $1.28M | Hold |
|
|||||
|
2015
Q2 | $1.58M | Buy |
|
|||||
|
2015
Q1 | $1.31M | Buy |
|
|||||
|
2014
Q4 | $1.38M | Hold |
|
|||||
|
2014
Q3 | $1.22M | Sell |
|
|||||
|
2014
Q2 | $1.32M | Sell |
|
|||||
|
2014
Q1 | $1.21M | Sell |
|
|||||
|
2013
Q4 | $1.51M | Buy |
|